The FDA approves Moderna’s “Spikevax” vaccine

Yesterday, the Food and Drug Administration approved Moderna’s COVID-19 vaccine for individuals 18 years of age and older. Upon approval, the Moderna vaccine will be marketed as “Spikevax.” The Emergency Use Authorization (EUA) of Moderna’s COVID-19 vaccine will remain in place for individuals 18 years of age and older. “The FDA’s approval of Spikevax is […]